Sign in

NCT03119883Completed

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Dysregulation of Glutamine Utilization in the Pathogenesis of Multiple Myeloma

Source: ClinicalTrials.gov · Last updated 9 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This clinical trial studies the utilization of glutamine by the bone marrow plasma cells from patients with monoclonal gammopathy of undetermined significance (MGUS) compared to multiple myeloma (MM). Results from this study may identify metabolic differences between pre-malignant and malignant clonal plasma cells in MGUS and MM, respectively. It may also allow researchers better determine the transition from MGUS to MM for the development of potential early diagnostic purposes of preventative strategies.

Status (registry)
Completed
Study type
Interventional
Enrollment
35 (actual)
First submitted
12 Apr 2017
Start date
2 Jun 2017
Primary completion date
30 Jun 2024
Lead sponsor
Mayo Clinic
NCT number
NCT03119883

What you commit to

  • Study type: Interventional
  • Participants enrolled: 35
  • From 2 Jun 2017 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of adverse events with conscious sedation

Lab values

  • Hemoglobin \< 8 g/dL

Other

  • Unable to provide consent
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) \> 3
  • Women who are pregnant

Who the study is looking for

  • At least 18 years of age
  • International Myeloma Working Group (IMWG) criteria for the diagnosis of either MGUS or MM

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.